UK Shares How Its Medtech Regs Already Diverge From The EU: COVID-19 Marks The Start
Executive Summary
The MHRA has updated its guidance on regulatory flexibilities for medical devices and medicinal products resulting from COVID-19 to highlight how its approach differs from the EU.